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Background:Rabies is still endemic in India causing an estimated 20,000 human deaths
a year. Free roaming dogs and unvaccinated owned dogs play a major role in the main-
tenance of the disease. Dog vaccination is the most crucial aspect of rabies prevention
and control strategies; therefore vaccine immunogenicity and longevity are important
determinants of the efficiency of rabies control efforts.
Methods: In this study atMadras Veterinary College, India, a total of 297 serum samples
were collected from owned dogs that were vaccinated against rabies. Data regarding age,
gender, breed, neuter status and last date of vaccination were collected at the time of
blood collection. The level of rabies virus neutralising antibodies in the sera of these dogs
was measured through rapid focus fluorescence inhibition test. The factors associated
with protective level of rabies antibodies in vaccinated dogs were investigated through
multivariable regression analysis.
Results: This cross-sectional investigation shows that only 40% (119/297) of the all the
dogs in the study showed presence of protective level of anti-rabies antibodies, and 40%
(72/180) of the dogs vaccinated within the last year showed presence of protective lev-
els of antibodies causing concern about rabies vaccine quality and its impact on rabies
control. The study also shows that older and neutered dogs are more likely to have pro-
tective titre among vaccinated dogs, while non-descript breed dogs are less likely to have
a protective titre compared to pure breeds.
Conclusion: In this study 60% (108/180) of young prima dogs and adult dogs did
not show protective levels of antibodies within the year of last rabies vaccination,
although they had previous vaccination history. This high percentage of apparent
non-responders is a cause of concern of administration, distribution, storage, potency
and quality management of vaccines in India.
INTRODUCTION
Dogs are the reservoir of rabies in most rabies endemic coun-
tries around the world.1 India is a rabies endemic country with
the largest estimated annual rabies deaths. It is estimated to
account for 35% of the world’s rabies deaths approximating to
20,000 deaths a year, causing an annual loss of 2.3 billion USD
through premature death, bite treatment, loss of labour, live-
stock losses and post-exposure prophylaxis.2 Dogs continue to
be the primary source of rabies in India and make up 96.2%
of the animal bites reported of which 75% are reported to be
from free roaming dogs.3
Dog populations in India can be broadly categorised into
three groups: 1) owned or pet dogs 2) community or partially
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited.
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owned and 3) free roaming. Owned or pet dogs are generally
confined with restricted movement and are always supervised
outside home. These dogs are completely dependent on their
owner for food and shelter. They receive regular veterinary
care and receive rabies vaccinationwhen the owner takes their
dogs to a private or government veterinary establishment or
if there is a door to door mass dog vaccination campaign.
Community or partially owned dogs are dogs that are partially
restricted or not supervised. They are partially dependent on
people for food and shelter. These dogs do not receive any
veterinary care. Free roaming dogs are completely free and do
not depend on people for food or shelter and do not receive
any veterinary care. The second and third groups of dogs have
a chance of receiving a shot of rabies vaccine only if there is
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mass dog vaccination or mass dog sterilization effort in the
region.
Free roaming and community dogs are seen as a pub-
lic menace for various reasons besides biting and rabies.4
There is also a concern of animal welfare when people
respond to the menace in inhumane ways; therefore the
public sector began focused efforts towards rabies and dog
population control through humane methods. These efforts
are apparent through mass dog sterilization initiatives or
catch-neuter-vaccinate-release programs in urban and semi-
urban areas in India,5,6 which started in 1992.7 Mass dog
vaccination campaigns targeting control of canine rabies are
also gaining gradual momentum in India.8 Rabies elimina-
tion through mass dog vaccination has been demonstrated
multiple times before,9,10 and World Organisation for Ani-
mal Health (OIE) and World Health Organisation (WHO)
recommend canine rabies control as a strategy in eliminating
dog mediated human rabies.11,12 The National Rabies Control
Programme under Government of India is also working in
tandem with the global goal ‘zero by 30′ initiated by the
tripartite to achieve zero human rabies deaths by the year
2030.13 The quality of the vaccine used to control rabies in
any group of dogs (owned, free roaming, community) and
in any delivery strategy (veterinary clinic, door to door,
mass dog vaccination) remains to be one of the most critical
components of this global goal.14
Since the quality of canine rabies vaccines is one of the
most critical factors in the efforts of rabies control, OIE and
WHO recommend that canine vaccines should confer protec-
tive immunity for at least 1 year11 and 2 years,12 respectively.
This study explores the presence and factors associated with
protective level of rabies antibody titres (PLORAT) in a vacci-
nated dog population sample in Chennai, India.
MATERIAL ANDMETHODS
Ethics statement
Clearance and approval of study protocol were obtained from
the Institutional Animal Ethics Committee of Tamil Nadu
Veterinary and Animal Sciences University for this study
(1252/B/DFBS/IBSC/2011/ dated 31/10/2011) which adheres to
the Committee for the Purpose of Control and Supervision of
Experiments on Animals, Government of India. None of the
authors have any competing interest in this study.
Sample collection
Blood was collected from dogs presented to Madras Vet-
erinary College outpatient section of the Clinical Medicine
Department, a government veterinary teaching hospital in
Chennai City with a primary to tertiary case load. Sera sam-
ples were collected from 8 September 2011 to 21 September
2012. All the samples in this study were collected from dogs
that had an owner who cared for and took full responsibility
for its health. Only eligible dogs of owners who understood
the objective of the study and consented were included in
the study. Dogs were eligible for inclusion in the study if they
were apparently healthy with good body score condition and
had been vaccinated for rabies any time before 3 weeks to
the day of blood collection. Vaccination cards were used as
a proof of vaccination whenever it was possible otherwise
most records for the date of vaccination are based on the
memory of the dog owners. If the owner could not remember
the last date of vaccination, the dog was not included in the
study. Additionally the dogs included needed to have their
prima rabies vaccine above the age of 3 months as recom-
mended by vaccine labels. All dogs included in the study
were vaccinated by vaccines approved by the Veterinary Cell,
Central Drugs Standard Control organisation, Directorate
General of Health Services (DGHS), Ministry of Health and
Family Welfare, Government of India. Dogs were excluded
if they had never received rabies immunization and/or were
clinically unhealthy. All dogs except 13 puppies aged less than
6 months had received at least two doses of rabies vaccine at
the time of blood collection. The brand names of the vaccines
were not recorded. Data regarding details of the dogs’ age,
gender, breed, neuter status and last date of vaccination were
collected at the time of blood collection using a structured
questionnaire by the author. The breed of the dogs was
assigned visually by the author from veterinary expertise.
Laboratory analysis
Rapid fluorescence focus inhibition test (RFFIT) was con-
ducted to estimate rabies antibody level in the sera of the dogs.
This was performed as per the WHO advocated procedure15
with some modifications at the Department of Neurovirol-
ogy, National Institute of Mental Health and Neurosciences
(NIMHANS), Bangalore, a WHO Collaborating Centre for
Reference and Research on Rabies. Instead of tissue culture
chambers, 96-well flat-bottomed tissue culture plates were
used, and the cell line used was Baby Hamster Kidney (BHK
−21). The virus used was a CVS strain adapted to grow in
BHK-21 cells, and the dose used was 100 FFD50. The highest
dilution of serum showing 50% inhibition of fluorescent foci
in the infected cells was taken as the titre of the serum, which
was converted to international units (IU/ml) by comparison
to an in-house reference sera calibrated against the 2nd
international reference serum with a unitage of 30 IU/ml
(obtained from the National Institute of Biologicals, UK).
Rabies neutralising antibody titre of 0.5 IU/ml is defined
‘protective’ by WHO and OIE.11
Statistical analysis
Data were analysed using the statistical software R 3.4.2.16
Two multivariable regression models were built in order to
identify factors associated with rabies antibody titres. A mul-
tivariable logistic regression model was used to identify fac-
tors associated with a dog having a protective antibody titre
(>0.47IU/ml), while a multivariable linear regression model
was used to identify factors associated with antibody titre lev-
els. To deal with missing values in the dataset, any variables
with missing values had an extra category added called ’miss-
ing’ to avoid rows being automatically removed by regression
analysis. This enabled the use of the whole dataset, therefore
avoiding bias due to absence of data.
Vaccinated dogs were grouped into three categories
depending on duration of time that had lapsed from the date
of last vaccination to time of blood collection: 1) vaccinated
within a year 2) vaccinated between 1 and 3 years and 3) more
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TABLE  Proportion of dogs with protective level of rabies antibody
titres (PLORAT) sorted according to the date of last vaccination
Vaccination time
Protective
titre Total Percentage % CI
Within this year 72 180 40.0 32.78–47.55
1–3 years ago 28 56 50.0 36.34–63.66
More than 3 years ago 2 9 22.2 2.81–60.01
Unknown 17 52 32.7 20.33–47.11
than 3 years ago. Dogs were also divided into three groups
based on their body weight and breed: 1) large breed included
dogs with defined breed and weighed more than 25 kg, 2)
small breed includeddogswith defined breed andweighed less
than 25 kg and 3) non-descript (ND) included mixed breed
dogs, dogs that were not defined as a breed, and the free roam-
ing dog variety popularly called “Indy”.
Univariable analysis was used as a pre-screening for select-
ing variables thatwould be considered in themultivariable lin-
ear and logistic regressionmodels, respectively. Variables with
a p-value < 0.15 were considered in the multivariable models.
Variable selection was carried out using the dredge function
from the MuMIn R package,17 whereby models with all vari-
able combinations are fit. The finalmodels were selected based
on corrected Akaike information criterion (AICc). Models
with an AICc within 2 units of the lowest AICc were averaged
to give the final model.
RESULTS
A total of 297 blood samples collected from dogs satisfied the
selection criteria, of which, 119 (40%) vaccinated dogs showed
PLORAT, while 60% did not. Table 1 and Figure 1 show the
proportion and distribution of dogs with PLORAT according
to the date of last vaccination. Only 40% (72/180) of dogs
vaccinated within the last year showed PLORAT, 50% (28/56)
of the dogs vaccinated during the last 1–3 years showed PLO-
RAT, 22.2% (2/9) of dogs vaccinated more than 3 years ago
showed PLORAT and 32.7% (17/52) of dogs with unknown
date of vaccination showed PLORAT. The proportion of the
dogs that showed a PLORAT and were vaccinated anytime
within 3 years was 42.4% (100/236).
Univariable analysis results for both logistic and linear
regression are shown in Tables 2 and 3, respectively. These
show all variables considered for analysis. Variables which sat-
isfied the p < 0.15 criterion were considered for inclusion in
the multivariable models.
Multivariable logistic regression (Figure 2a) showed that
neutered dogs have almost four times greater odds of protec-
tive antibody titres over intact dogs. Compared to dogs vacci-
nated during the last year, dogs vaccinated more than 3 years
ago have almost four times lower odds of having a protective
titre. Also, compared to ND breed dogs, both small and large
breed dogs have around twice the odds of having a protective
titre. The odds of having a protective titre also increased with
age. In other words, older dogs have greater odds of having
protective titres.
Multivariable linear regression (Figure 2b) supported these
results by showing that neutered dogs had higher titres than
entire dogs. Similarly, antibody titre increasedwith age. Lastly,
ND breed dogs had lower titres than small and large breed
dogs. Numerical results of the regressionmodels can be found
in Tables 4 and 5.
DISCUSSION
In our study 60% of young prima dogs and adult dogs did
not show protective levels of antibodies within the year of
their last rabies vaccination, although they had a previous
vaccination history. This high percentage of apparent non-
responders is a cause of concern. There are various reasons
F IGURE  Distribution of dogs with protective level of rabies antibody titres (PLORAT) sorted according to the date of last vaccination
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TABLE  Univariable analysis for logistic regression model predicting presence of protective antibody titre
Variable Odds ratio % confidence interval p-value
Age (months) 1.01 1–1.02 0.001
Sex
Female 1 Reference category
Male 0.92 0.58–1.46 0.72
Breed
Non-descript 1 Reference category
Breed: Small 2.35 1.06–5.24 0.036
Breed: Large 1.76 0.91–3.43 0.094
Neuter status
Entire 1 Reference category
Neutered 4.88 1.53–15.51 0.007
Number of days since last vaccination 1 1 0.919
Time since last vaccination
Within this year 1 Reference category
1–3 years ago 1.5 0.82–2.74 0.187
More than 3 years ago 0.43 0.09–2.12 0.299
Vaccination frequency
Irregular 1 Reference category
Regular (annually) 0.95 0.5–1.8 0.864
TABLE  Univariable analysis for linear regression model predicting antibody titre
Variable Estimate % confidence interval p-value
Age (months) 0 0-0.01 0.03
Sex
Female 1 Reference category
Male −0.05 −0.27–0.17 0.64
Breed
Non-descript 1 Reference category
Breed: Small 0.53 0.17–0.89 0.004
Breed: Large 0.19 −0.1–0.48 0.204
Neuter status
Entire 1 Reference category
Neutered 0.86 0.39–1.34 0
Number of days since last vaccination 0 0-0 0.305
Time since last vaccination
Within this year 1 Reference category
1–3 years ago −0.12 −0.42–0.17 0.416
More than 3 years ago −0.46 −1.13–0.2 0.173
Vaccination frequency
Irregular 1 Reference category
Regular (annually) 0.07 -0.26–0.4 0.676
why vaccination of dogs with inactivated rabies vaccines
does not lead to neutralising antibody levels considered to
be protective including intrinsic animal and extrinsic vaccine
factors.18 The factors that can be completely controlled are
the extrinsic factors that pertain to vaccine quality by man-
ufacturers, cold chain maintenance by distributor and final
stage suppliers, storage and administration by veterinarians.
Inadequate levels of protective antibody in the first year of
vaccination after a single dose of primary rabies immuniza-
tion have been reported in the range of 3.1%–51%.19–23 Studies
have therefore emphasised the need of a booster dose of rabies
vaccine in puppies and dogs under the age of one to reach pro-
tective levels of antibodies within the first year.23,24
OIE andDGHS of India recommend that canine rabies vac-
cines should confer a minimum of 1 year immunity in dogs,
and yet only 40% of the dogs vaccinated within a year showed
protective antibody titres depicting a 60% failure to reach
PLORAT. Most vaccine labels promise 3 years of immunity,
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F IGURE  Results of the multivariable logistic (a) and linear (b) regression models predicting presence of protective antibody titre and antibody titre
levels, respectively. Odds ratios (dots) and 95% confidence intervals (lines) are shown for each model
TABLE  Multivariable logistic regression model predicting presence of protective antibody titre
Variable Odds ratio % confidence interval Standard error p-value
Age (months) 1.008 1.002–1.014 0.003 0.009
Neuter status: Entire 1 Reference category
Neuter status: Neutered 3.782 1.136–12.587 0.611 0.030
Breed: Non-descript 1 Reference category
Breed: Small 2.198 0.947–5.101 0.428 0.067
Breed: Large 1.813 0.906–3.628 0.352 0.093
Time since last vaccination: Within the year 1 Reference category
Time since last vaccination:1–3 years ago 1.366 0.731–2.550 0.317 0.328
Time since last vaccination: More than 3 years ago 0.287 0.054–1.524 0.848 0.143
Time since last vaccination: Missing 0.764 0.390–1.494 0.341 0.431
and yet only 42.4% (100/236) of the dogs that were vaccinated
within a total of 3 years showed protective levels of immunity.
Absence of protective levels of rabies virus neutralising
antibody titres in vaccinated dogs does not necessarily indi-
cate that they are susceptible to rabies infection if challenged
but there is inadequate information regarding the outcome
in dogs that merely seroconvert and do not reach protective
levels. Kennedy et al25 discussed that the dog’s total immunity
does not reduce but only shifts from a more dominant IgM to
a more IgG-based immunity. Additionally, the role of cellular
TABLE  Multivariable linear regression model predicting antibody titre levels
Variable Estimate % confidence interval Standard error p-value
Breed: Non-descript 1 Reference category
Breed: Small 0.552 0.194–0.911 0.182 0.003
Breed: Large 0.206 −0.080–0.491 0.145 0.158
Neuter status: Entire 1 Reference category
Neuter status: Neutered 0.882 0.402–1.361 0.244 <0.01
Age (months) 0.001 −0.0014444–0.004 0.001 0.367
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immunity and antibodies other than neutralising antibod-
ies that contribute towards immunity from rabies requires
further investigation to understand the protection that is
observed sometimes in animals that do not show PLORAT or
animals that show neutralising antibodies without previous
vaccination.26–28 Our study reports results fromRFFIT, which
is a gold standard technique for virus neutralising antibody
technique.29
The humoral response to parenteral anti-rabies vaccination
shows a classic profilewhere the immune response beginswith
a latent phase followed by an exponential phase and a plateau,
then a decrease in the antibody levels. The peak is generally
reached between 4 and 6 weeks and remains stable through-
out the year with a short period of low phase between 16 and
25 weeks before waning down gradually over the following
year.19,23 Since the exact date of vaccination is unknown in
most of the cases in this study, samples could have been col-
lected in the low phase of immune response leading to high
proportion of low responders in the first group; dogswere vac-
cinated within a year.
As age increased, odds of a PLORAT increased. This can
be explained by the well-established fact that adult dogs and
dogs that have received multiple doses of vaccination over the
years have a better chance to result in PLORAT.19,30 Addi-
tional detailed information on previous vaccinations of the
dogs in this study would contribute significantly to the results
obtained; the authors recognise this as a limitation in the study
since this informationwas not precisely available from the dog
owners.
Dogs that were vaccinated 1–3 years ago showed contra-
dicting results where 50% of them tested with PLORAT lead-
ing the category to slightly higher odds of PLORAT compared
to dogs vaccinated within the last year. These results are sus-
pected to be skewed by the possibility that the dogs presented
with last dose of vaccination 1–3 years ago to be older dogs
who had received multiple doses of annual rabies vaccination
previously.
Neutered dogs in the study showed greater odds of PLO-
RAT than intact dogs, a result that was comparable with work
by Kennedy et al25 which indicated that neutering increased
the chances of PLORAT by 22%. Nevertheless, there is still
debate about the effect of neutering on health, and the results
could be confounded by the fact that neutered dogswere prob-
ably cared for better than dogs that were not; assuming neu-
tering reflects responsible ownership and better care.30,31
Our study shows a very high percentage of low responders
(less than PLORAT) in spite of all dogs included in the study
being owned. Owned dogs have regular access to food, veteri-
nary care and shelter compared to free roaming dogs that do
not have a healthy diet, veterinary care or comfortable shelter.
Additionally our analysis shows that theNDdogs in our group
had lower odds of achieving PLORAT compared to pure-bred
dogs, although mixed breeds have been known to show bet-
ter immune response to vaccine in other reports.23 A possi-
ble explanation might be that owners of ND dogs resorted to
lower priced, lower quality vaccines.32
A mass dog vaccination campaign in India costs approx-
imately 250 INR (3.5 USD) per dog with 70% of the total
being operational costs (staff salaries, vehicles, fuel, equip-
ment, needle-syringe etc). The cost of the vaccine is only
approximately 30% of the campaign expenditure,33 but a
substandard vaccine has the potential to jeopardise the entire
campaign as previously experienced in other mass dog vac-
cination efforts.34 Additionally, dogs in mass vaccination
programs receive a single dose of vaccine with no chance of a
booster within the year. Hence the quality of vaccines used in
these programs should be high enough to induce significant
protection with a single immunization.
Mass dog vaccination campaigns and veterinary public
sector must have the power of judgement on the quality of
vaccine during procurement, factoring in duration of immu-
nity, thermos-stability and efficacy35,36 and not be completely
bound by the tender process of lowest bidder as it may jeop-
ardise the quality of the vaccine purchased and hence the
whole control effort. A more stringent vaccine quality control
measure is required to be enforced for efficient infectious dis-
ease control including random serological potency assays36,37
by government appointed independent agencies at end user
stage to monitor quality of the vaccines administered. Higher
proportion of protective levels of antibody titres has been
reported in other studies demonstrating the possibility of
better seroconversion and maintenance of adequate levels
of antibodies.28,38,39 A randomised control trial to compare
potency of different vaccine brands available in India would
challenge this discussion providing insight towards better
solutions.
CONCLUSION
In this study 60% of vaccinated dogs showed inadequate pro-
tective levels of titres within the year of last rabies vaccination
in 180 vaccinated dogs in Chennai, India. This proportion is
far higher than other reports from similar studies.40–42 This
is not only a concern for rabies control efforts in the canine
population but also increases the risk of rabies in humans
whomay not seek post-exposure prophylaxis after a bite from
a vaccinated dog. It is crucial that vaccines selected for use
by the veterinary public sector and for mass dog vaccination
campaigns are of high quality and retain potency until admin-
istration. Regular investigation through neutral agencies is
required to ensure quality of vaccines is maintained from pro-
duction to administration.
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